Trials / Sponsors / Algernon Pharmaceuticals
Algernon Pharmaceuticals
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Single and Repeat Doses of DMT in Healthy Subjects Stroke | Phase 1 | 2023-01-13 |
| Completed | Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 D COVID | Phase 2 / Phase 3 | 2020-08-05 |
| Completed | Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough Idiopathic Pulmonary Fibrosis | Phase 2 | 2020-07-29 |